M. Burns

发表

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Menggang Yu, J. Leblanc, H. Cárdenes, 2012, Cancer Chemotherapy and Pharmacology.

A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma

C. Yiannoutsos, P. Loehrer, O. Gbolahan, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I/II study of everolimus (E) with irinotecan (Iri) and cetuximab (C) in 2nd line metastatic colorectal cancer (mCRC): Hoosier Cancer Research Network GI05-102.

J. Picus, E. Chiorean, P. Loehrer, 2015 .

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies.

H. Wakelee, S. Perkins, M. Gubens, 2015, Lung cancer.

A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma

R. Nelson, S. Perkins, B. Schneider, 2008 .

Phase II study of gefitinib treatment in advanced thymic malignancies

W. Pao, P. Loehrer, M. Burns, 2005 .

The Toxicology Investigators Consortium 2020 Annual Report

Michael V. LeVine, P. Wax, H. Farrar, 2021, Journal of Medical Toxicology.

Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.

K. Ramchandran, J. Neal, H. Wakelee, 2019, Lung cancer.

Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience

Zhangsheng Yu, H. Cárdenes, E. Chiorean, 2017, American journal of clinical oncology.

Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies

K. Ramchandran, J. Neal, H. Wakelee, 2015 .

A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma.

C. Yiannoutsos, R. Nelson, E. Chiorean, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).

K. Ramchandran, J. Neal, H. Wakelee, 2015 .

EP1.04-12 Response to Combination of Metformin and Nivolumab in a NSCLC Patient Whose Disease Previously Progressed on Nivolumab

Y. Chae, Sarika Jain, P. Viveiros, 2019, Journal of Thoracic Oncology.

Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3

K. Bushara, C. Lenglet, J. Schmahmann, 2022, Annals of neurology.

Phase I study of everolimus (RAD001) with irinotecan (Iri) and cetuximab (C) in second-line metastatic colorectal cancer (mCRC): Hoosier Oncology Group GI05-102-Final report.

J. Picus, G. Vance, E. Chiorean, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.